Clinical trial
Study of Photodynamic Therapy in Patients With Prostate Cancer Following…
NCT00308919 · STEBA France, Industry · Completed
Key facts
| NCT number | NCT00308919 |
|---|---|
| Title | Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy |
| Official title | Phase II Study of Photodynamic Therapy With WST-09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure : Effect of the Light Dose and the Number of Fibres |
| Lead sponsor | STEBA France, Industry |
| Collaborators | University Health Network, Toronto |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure |
| Intervention type | Drug |
| Interventions | WST09 |
| Enrollment | 28 |
| Start date | Apr 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Mar 30, 2006 |
| Last update posted | Jun 22, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: